ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,996, issued on Oct. 7, was assigned to mySugr GmbH (Vienna).

"System and method for detecting issues in the basal rate in insulin treated diabetes patients" was invented by Fredrik Debong (Vienna), Lukas Schuster (Vienna), Jan Wrede (Salzgitter-Bad, Germany) and Rafael Bankosegger (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "A system for determining a deficiency in an infusion rate for a user has a processor, a display, a memory and, optionally, one or more of a pump and an analyte monitor. The processor receives measured glucose values that each have a timestamp indicating the time/date of measurement. The processor determines whether the ...